Skip to content
Search

Latest Stories

Mattel introduces first Barbie doll with type 1 diabetes to promote inclusion

The diabetes Barbie doll was developed in collaboration with Breakthrough T1D

Barbie with type 1 diabetes

This is also part of Mattel’s mission to extend the boundaries of imaginative play

Mattel

Highlights

  • Mattel launches new Barbie with type 1 diabetes
  • The doll features a glucose monitor, insulin pump and CGM app
  • Created in collaboration with type 1 diabetes charity Breakthrough T1D
  • Part of Mattel’s broader push for inclusivity and representation in toys

Barbie with type 1 diabetes joins inclusive fashionistas range

Mattel has launched its first diabetes Barbie doll, designed to represent children with type 1 diabetes and promote greater inclusivity in children’s toys.

The new addition to the Barbie Fashionistas line comes with realistic medical features including a continuous glucose monitor (CGM) on her arm, secured with heart-shaped medical tape, and an insulin pump to help manage her blood sugar levels. She also carries a smartphone with a CGM app to monitor glucose throughout the day, and a bag large enough to store snacks and other essentials.


Designed in partnership with Breakthrough T1D

The diabetes Barbie doll was developed in collaboration with Breakthrough T1D, a global not-for-profit organisation supporting people with type 1 diabetes (T1D). The autoimmune condition typically develops in childhood and requires patients to monitor their blood glucose and take insulin regularly.

Krista Berger, senior vice-president of Barbie and global head of dolls, described the launch as “an important step in our commitment to inclusivity and representation.”

“Barbie helps shape children’s early perceptions of the world, and by reflecting medical conditions like T1D, we ensure more kids can see themselves in the stories they imagine and the dolls they love,” she said.

Karen Addington, CEO of Breakthrough T1D UK, welcomed the collaboration: “I’m absolutely thrilled that Barbie now includes a doll with type 1 diabetes. For children with T1D who don’t often see themselves represented, this doll will be a powerful role model, celebrating their strength and bringing recognition, inclusion and joy to their play.”

A growing legacy of inclusive design

Since the original Barbie’s debut in 1959, the brand has evolved to reflect greater diversity. The first Black Barbie dolls were introduced in the 1960s, followed by Hispanic dolls in the 1980s. From the 1990s onwards, Mattel expanded the range to include Barbies in under-represented careers such as astronauts and scientists.

It wasn’t until 2019 that Barbie dolls with visible disabilities were introduced. Since then, Mattel has launched more than 175 diverse Barbie looks as part of the Fashionistas range, which now includes dolls with hearing aids, prosthetic limbs, wheelchairs, vitiligo, and Down’s syndrome. A black Barbie with Down’s syndrome and a blind Barbie are also part of the line.

The diabetes Barbie doll continues that trend, offering children with the condition a chance to see themselves positively reflected in their toys.

Industry-wide shift toward representation

Barbie is not the only toy brand prioritising diversity. UK-based brand Lottie includes dolls with autism and Down’s syndrome, while Lego offers a variety of inclusive minifigures, including characters with physical and non-visible disabilities.

Arjun Panesar, founding chief executive of Diabetes.co.uk, praised Mattel’s decision, stating: “Representation matters – especially in childhood. Seeing a Barbie doll with type 1 diabetes helps normalise the condition, reduce stigma and show children that they are not alone.

“It’s a positive step forward in building confidence, inclusion and understanding around living with diabetes.”

Promoting empathy through play

The launch of the diabetes Barbie doll is not just about inclusion—it is also part of Mattel’s mission to extend the boundaries of imaginative play. The company says the goal is to encourage children to engage with experiences beyond their own, helping them to understand the challenges others may face.

As Barbie continues to evolve, the inclusion of realistic medical conditions such as type 1 diabetes signals a more inclusive future for toys and the children who play with them.

More For You

Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less
Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images

Tennis champion Monica Seles reveals living with myasthenia gravis

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Keep ReadingShow less
faulty knee implant NHS recall

Hundreds of patients required corrective surgery

iStock

Faulty knee implant recalled after being used in over 10,000 NHS surgeries

Highlights:

  • NexGen knee implant linked to high failure rates was used in over 10,000 UK operations.
  • Concerns flagged as early as 2014; withdrawn from UK market in 2022.
  • Hundreds of patients required corrective surgery, with costs running into millions.
  • Manufacturer Zimmer Biomet says patient safety is its “top priority” but will not cover revision costs up front.

Implant used despite early warnings

A knee replacement implant used in thousands of NHS operations was known to have a concerning failure rate eight years before it was withdrawn, a BBC File on 4 Investigates report has found.

The NexGen implant, made by US manufacturer Zimmer Biomet, was fitted in more than 10,000 patients between 2012 and 2022. Concerns were first raised by the National Joint Registry (NJR) in 2014, though insufficient data at the time made it difficult to draw firm conclusions.

Keep ReadingShow less
health

A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV

iStock

Oral sex linked to skin cancer risk through stealth HPV infections, scientists warn

Highlights:

  • HPV, a common STI, is now potentially linked to a deadly form of skin cancer
  • A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV
  • Researchers say this discovery could shift the approach to diagnosing and treating some skin cancers
  • Protection measures include vaccination, safe sex practices, and regular screening


Human papillomavirus (HPV), one of the most widespread sexually transmitted infections in the UK, is already associated with several serious cancers — cervical, throat, penile, anal, and head and neck cancers among them. Now, researchers in the US have raised concerns that it may also contribute to certain forms of skin cancer, especially in people with weakened immune systems.

Scientists from the National Institutes of Health (NIH) found signs of beta-HPV triggering squamous cell carcinoma in a young woman who had no major history of sun damage or other typical causes.

Keep ReadingShow less
CardioPrecision

The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes

MediaZoo

CardioPrecision performs world-first robot-assisted aortic valve replacement via neck incision

Highlights:

  • Glasgow-based CardioPrecision completes first clinical cases of robotic aortic valve replacement (AVR) through a small neck incision.
  • The procedure was carried out at Cleveland Clinic in the United States.
  • It uses the company’s CoreVista® Robot Enabling Platform to perform minimally invasive surgery.
  • The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes.
  • Early results presented at major international conferences show clinical promise.


Glasgow medtech firm CardioPrecision has successfully performed the world’s first clinical cases of robot-assisted aortic valve replacement (AVR) using a small transcervical incision. This breakthrough could significantly reduce the need for traditional open-heart surgery.

The pioneering operations were carried out at the Cleveland Clinic in the United States, a centre globally recognised for its cardiovascular care. The procedures used CardioPrecision’s proprietary CoreVista® Robot Enabling Platform, offering a new route for accessing the heart valve via the neck rather than the chest.

Keep ReadingShow less